This FDA-approved drug promises a new way to treat schizophrenia
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
eNCA18hOpinion
New drug for schizophrenics has experts excited
WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for ...
stockhead17h
Market Highlights: All eyes on another ASX record, and why investors could pile on stocks before year-end
ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.
The Pharma Letter18h
The week in pharma: action, reaction and insight – week to September 27
Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...
Adelaide Now1h
ASX Small Caps Lunch Wrap: Benchmark moves to record highs as iron ore momentum builds
Bristol Myers Squibb climbed 1.5% after the FDA approved its schizophrenia drug. This marks the first new treatment option ...
Reuters15h
United States
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Australian Broadcasting Corporation17h
ABC News
Photo shows A bundle of bright backpacks sits on the ground with a child lying down in the middle in front of a group of huddled people ...